Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features

Cancer Genetics and Cytogenetics

Volumn 197, Issue 1, 2010, Pages 39-45

  Lee, Su Man ^a   Lee, Ji Yun ^a   Choi, Jin Eun ^b   Lee, Shin Yup ^b   Park, Jae Yong ^b   Kim, Dong Sun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 74749089384     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.10.008     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics 2007. CA Cancer J Clin 57 (2007) 43-66
2. Minna J.D., Roth J.A., and Gazdar A.F. Focus on lung cancer. Cancer Cell 1 (2002) 49-52
3. Lotan R., and Clifford J.L. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 45 (1991) 145-156
4. Chambon P. A decade of molecular biology of retinoid acid receptors. FASEB J 10 (1996) 940-954
5. Sun S.Y., and Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41 (2002) 41-55
6. Soprano D.R., Qin P., and Soprano K.J. Retinoic acid receptors and cancers. Annu Rev Nutr 24 (2004) 201-221
7. Allenby G., Bocquel M.T., Saunders M., Kazmer S., Specl J., Rosenberg M., Lovey A., Kastner P., Grippo J.F., Chambon P., and Levin A.A. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90 (1993) 30-34
8. Leid M., Kastner P., and Chambon P. Multiplicity generates diversity in the retinoic acid signaling pathways. Trend Biochem Sci 17 (1992) 427-433
9. Xu X.C., Sozzi G., Lee J.S., Lee J.J., Pastorino U., Pilotti S., Kurie J.M., Hong W.K., and Lotan R. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo. J Natl Cancer Inst 89 (1997) 624-629
10. Picard E., Seguin C., Monhoven N., Rochette-Egly C., Siat J., Borrelly J., Martinet Y., Martinet N., and Vignaud J.M. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 91 (1999) 1059-1066
11. Chakravarti N., Mathur M., Bahadur S., Kumar Shukla N., and Ralhan R. Retinoic acid receptor-alpha as a prognostic indicator in oral squamous cell carcinoma. Int J Cancer 103 (2003) 544-549
12. Brabender J., Metzger R., Salonga D., Danenberg K.D., Danenberg P.V., Hölscher A.H., and Schneider P.M. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis 26 (2005) 525-530
13. Khuri F.R., Lotan R., and Kemp B.L. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small cell lung cancer. J Clin Oncol 18 (2000) 2798-2804
14. Tsou J.A., Hagen J.A., Carpenter C.L., and Laird-Offringa I.A. DNA hypermethylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21 (2002) 5450-5461
15. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4 (2004) 707-717
16. Kim D.S., Cha S.I., Lee J.H., Lee Y.M., Choi J.E., Kim M.J., Lim J.S., Lee E.B., Kim C.H., Park T.I., Jung T.H., and Park J.Y. Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer 58 (2007) 1-6
17. Widschwendter M., Berger J., Hermann M., Muller H.M., Amberger A., Zeschnigk M., Widschwendter A., Abendstein B., Zeimet A.G., Daxenbichler G., and Marth C. Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer. J Natl Cancer Inst 92 (2000) 826-832
18. Virmani A.K., Rathi A., Zöchbauer-Müller S., Sacchi N., Fukuyama Y., Bryant D., Maitra A., Heda S., Fong K.M., Thunnissen F., Minna J.D., and Gazdar A.F. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas. J Natl Cancer Inst 92 (2000) 1303-1307
19. Kim D.S., Kim M.J., Lee J.Y., Lee S.M., Choi J.E., Park J.Y., and Kim D.S. Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features. Lung Cancer 65 (2009) 247-250
20. Herman J.G., Graff J.R., Myöhänen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 (1996) 9821-9826
21. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., and Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334 (1996) 1150-1155
22. Lippman S.M., Lee J.J., Karp D.D., Vokes E.E., Benner S.E., Goodman G.E., Khuri F.R., Marks R., Winn R.J., Fry W., Graziano S.L., Gandara D.R., Okawara G., Woodhouse C.L., Williams B., Perez C., Kim H.W., Lotan R., Roth J.A., and Hong W.K. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small cell lung cancer. J Natl Cancer Inst 93 (2001) 605-618